{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:00:03Z","timestamp":1792029603616,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114444","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:17:41Z","timestamp":1741911461000},"page":"114444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: Multi-center, randomized, controlled trials"],"prefix":"10.1016","volume":"152","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuekai","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangyou","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114444_bb0005","first-page":"1","article-title":"International clinical practice guideline on the use of traditional Chinese medicine for ulcerative colitis by Board of Specialty Committee of digestive system disease of world Federation of Chinese Medicine Societies (2023)","volume":"2023","author":"Zhang","year":"2023","journal-title":"Phytother. Res."},{"issue":"10401","key":"10.1016\/j.intimp.2025.114444_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.intimp.2025.114444_bb0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative colitis in adults: a review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.intimp.2025.114444_bb0020","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3748\/wjg.v12.i23.3636","article-title":"Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis","volume":"12","author":"Annese","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114444_bb0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Craig","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2025.114444_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13020-022-00673-w","article-title":"Understanding the tonifying and the detoxifying properties of Chinese medicines from their impacts on gut microbiota and host metabolism: a case study with four medicinal herbs in experimental colitis rat model","volume":"17","author":"Li","year":"2022","journal-title":"Chin. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.114444_bb0035","first-page":"1326","article-title":"Hudi enteric-coated capsule combined with Mesalazine enteric-coated tablet for active ulcerative colitis: a multi-Centre, randomized, double-blinded and double-simulated clinical study","volume":"39","author":"Shen","year":"2019","journal-title":"Chin. J. Tradit. West Med."},{"issue":"35","key":"10.1016\/j.intimp.2025.114444_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021903","article-title":"Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis a multi-center, randomized, double-blind, controlled trial","volume":"99","author":"Kou","year":"2020","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.intimp.2025.114444_bb0045","first-page":"15","article-title":"Therapeutic analysis of Qingchang Wenzhong formula for treatment of mild-moderate ulcerative colitis patients","volume":"38","author":"Wang","year":"2018","journal-title":"Chin. J. Tradit. West Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114444_bb0050","first-page":"28","article-title":"The clinical effect of Qingchang Wenzhong decoction in the treatment of ulcerative colitis and its impact on intestinal mucosal barrier function of patients","volume":"43","author":"Zhang","year":"2023","journal-title":"Chin. J. Coloproctol."},{"key":"10.1016\/j.intimp.2025.114444_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4846876","article-title":"Qingchang Wenzhong decoction attenuates DSS-induced colitis in rats by reducing inflammation and improving intestinal barrier function via upregulating the MSP\/RON signalling pathway","volume":"2017","author":"Mao","year":"2017","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114444_bb0060","doi-asserted-by":"crossref","first-page":"9979","DOI":"10.1002\/jcb.28280","article-title":"The inhibitory effects of Qingchang Wenzhong granule on the interactive network of inflammation, oxidative stress, and apoptosis in rats with dextran sulfate sodium-induced colitis","volume":"120","author":"Shi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2025.114444_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.738152","article-title":"Qingchang Wenzhong decoction accelerates intestinal mucosal healing through modulation of dysregulated gut microbiome, intestinal barrier and immune responses in mice","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114444_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9839474","article-title":"Gut microbiota-mediated NLRP12 expression drives the attenuation of dextran sulphate sodium-induced ulcerative colitis by Qingchang Wenzhong decoction","volume":"2019","author":"Sun","year":"2019","journal-title":"Evid-Based. Compl. Alt."},{"issue":"8","key":"10.1016\/j.intimp.2025.114444_bb0075","first-page":"1336","article-title":"Effect of Hudi enteric-coated capsules on the repairment of mucus barrier injury of ulcerative colitis mice induced by DSS","volume":"30","author":"Ding","year":"2021","journal-title":"J. Emerg. Tradit. Chin. Med."},{"key":"10.1016\/j.intimp.2025.114444_bb0080","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.2147\/DDDT.S326029","article-title":"Investigation of the active ingredients and mechanism of Hudi enteric-coated capsules in DSS-induced ulcerative colitis mice based on network pharmacology and experimental verification","volume":"15","author":"Ding","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2025.114444_bb0085","first-page":"44","article-title":"Systematic review and meta-analysis of Wumei pill in treating ulcerative colitis","volume":"52","author":"Wu","year":"2021","journal-title":"Jiangxi J. Tradit. Chin. Med."},{"issue":"34","key":"10.1016\/j.intimp.2025.114444_bb0090","first-page":"154","article-title":"Professor Li Junxiang\u2019s experience in treating chronic recurrent ulcerative colitis with new Wumei pills","volume":"20","author":"Deng","year":"2023","journal-title":"China Medical Herald"},{"key":"10.1016\/j.intimp.2025.114444_bb0095","first-page":"1","article-title":"Regulatory effects of modified Wumei pill on Th17\/Treg balance and intestinal microbiota in ulcerative colitis with damp-heat syndrome based on a human flora-associated model","author":"Zhang","year":"2024","journal-title":"Chin. J. Exp. Trad. Med. Formulae"},{"issue":"8","key":"10.1016\/j.intimp.2025.114444_bb0100","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.immuni.2021.07.004","article-title":"Multiomics analyses reveal a critical role of selenium in controlling T cell differentiation in Crohn's disease","volume":"54","author":"Huang","year":"2021","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2025.114444_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2290315","article-title":"Gut microbiota-derived 12-ketolithocholic acid suppresses the IL-17A secretion from colonic group 3 innate lymphoid cells to prevent the acute exacerbation of ulcerative colitis","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.intimp.2025.114444_bb0110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jgh.15232","article-title":"Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis","volume":"36","author":"Kedia","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114444_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01072-16","article-title":"Disease severity and immune activity relate to distinct interkingdom gut microbiome states in ethnically distinct ulcerative colitis patients","volume":"7","author":"Mar","year":"2016","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.intimp.2025.114444_bb0120","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.chom.2018.09.009","article-title":"Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course","volume":"24","author":"Schirmer","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.intimp.2025.114444_bb0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114444_bb0130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s13238-020-00784-w","article-title":"Role of gut microbiota in identification of novel TCM-derived active metabolites","volume":"12","author":"Lin","year":"2021","journal-title":"Protein Cell"},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2025.114444_bb0135","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2025.114444_bb0140","unstructured":"Y. Lin, W.-z. Yang, Q.-y. Wang, Y. Xu-wei, Clinical study on Hudi enteric-coated capsules combined with mesalazine in treatment of ulcerative colitis, Drugs & Clinic 34 (9) (2019) 2778\u20132781."},{"key":"10.1016\/j.intimp.2025.114444_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2147\/JIR.S395331","article-title":"Clinical significance and diagnostic utility of NLR LMR, PLR and SII in the course of COVID-19: a literature review","volume":"16","author":"Kosidlo","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.114444_bb0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cca.2021.02.016","article-title":"Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients","volume":"517","author":"Xie","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2025.114444_bb0155","article-title":"Inflammatory indexes for assessing the severity and disease progression of ulcerative colitis: a single-center retrospective study","volume":"10","author":"Lin","year":"2022","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.intimp.2025.114444_bb0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1890\/12-2010.1","article-title":"PERMANOVA, ANOSIM, and the mantel test in the face of heterogeneous dispersions: what null hypothesis are you testing?","volume":"83","author":"Anderson","year":"2013","journal-title":"Ecol. Monogr."},{"issue":"W1","key":"10.1016\/j.intimp.2025.114444_bb0165","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.114444_bb0170","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1021\/acs.jproteome.5b00354","article-title":"Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses","volume":"14","author":"Thevenot","year":"2015","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114444_bb0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Stat Methodol."},{"key":"10.1016\/j.intimp.2025.114444_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3467419","article-title":"The relationship between c-reactive protein\/albumin ratio and disease activity in patients with inflammatory bowel disease","volume":"2020","author":"Chen","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.intimp.2025.114444_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103062","article-title":"Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation","volume":"141","author":"Wu","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2025.114444_bb0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fphar.2019.00158","article-title":"Emerging applications of metabolomics in traditional Chinese medicine treating hypertension: biomarkers, pathways and more","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114444_bb0195","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1039\/C8NP00041G","article-title":"Interaction between gut microbiota and ethnomedicine constituents","volume":"36","author":"Wu","year":"2019","journal-title":"Nat. Prod. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.114444_bb0200","first-page":"5","article-title":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill","volume":"102","author":"Zahorec","year":"2001","journal-title":"Bratisl. Lek. Listy"},{"issue":"5","key":"10.1016\/j.intimp.2025.114444_bb0205","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.surg.2007.12.014","article-title":"The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer","volume":"143","author":"Smith","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.intimp.2025.114444_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6517549","article-title":"Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease","volume":"2019","author":"Xu","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"23","key":"10.1016\/j.intimp.2025.114444_bb0215","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"04","key":"10.1016\/j.intimp.2025.114444_bb0220","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1142\/S0192415X21500385","article-title":"Colorectal cancer, gut microbiota and traditional chinese medicine: a systematic review","volume":"49","author":"Zhao","year":"2021","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.intimp.2025.114444_bb0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.phrs.2019.02.024","article-title":"Gut microbiota, a new frontier to understand traditional Chinese medicines","volume":"142","author":"Feng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.114444_bb0230","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/CIA.S414714","article-title":"Gut microbiota and aging: traditional Chinese medicine and modern medicine","volume":"18","author":"Li","year":"2023","journal-title":"Clin. Interv. Aging"},{"issue":"6","key":"10.1016\/j.intimp.2025.114444_bb0235","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/MIB.0000000000001130","article-title":"The mucosal antibacterial response profile and fecal microbiota composition are linked to the disease course in patients with newly diagnosed ulcerative colitis","volume":"23","author":"Magnusson","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.114444_bb0240","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13059-019-1879-9","article-title":"Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host","volume":"20","author":"Seishima","year":"2019","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114444_bb0245","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1053\/j.gastro.2011.05.035","article-title":"Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation","volume":"141","author":"Steck","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2025.114444_bb0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2020.05.048","article-title":"The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis","volume":"182","author":"Kitamoto","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.114444_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104707","article-title":"Changes in intestinal microbiota and correlation with TLRs in ulcerative colitis in the coastal area of northern China","volume":"150","author":"Xu","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2025.114444_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2024.01.004","article-title":"Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice","volume":"187","author":"Fu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.114444_bb0265","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2028366","article-title":"A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach","volume":"14","author":"Barberio","year":"2022","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.intimp.2025.114444_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40168-019-0704-8","article-title":"Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health","volume":"7","author":"Oliphant","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.intimp.2025.114444_bb0275","article-title":"Diet-mediated metaorganismal relay biotransformation: health effects and pathways","volume":"1-19","author":"Li","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.intimp.2025.114444_bb0280","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/pr060470d","article-title":"Rapid and noninvasive metabonomic characterization of inflammatory bowel disease","volume":"6","author":"Marchesi","year":"2007","journal-title":"J. Proteome Res."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2025.114444_bb0285","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijmm.2007.07.016","article-title":"Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease","volume":"298","author":"Takaishi","year":"2008","journal-title":"Int. J. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114444_bb0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41577-019-0252-2","article-title":"Immune recognition of microbial metabolites","volume":"20","author":"Garrett","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.114444_bb0295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fimmu.2019.00426","article-title":"Microbiome dependent regulation of Tregs and Th17 cells in mucosa","volume":"10","author":"Pandiyan","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114444_bb0300","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.09.014","article-title":"Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity","volume":"51","author":"Chun","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2025.114444_bb0305","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190489","article-title":"Acetate coordinates neutrophil and ILC3 responses against C. Difficile through FFAR2","volume":"217","author":"Fachi","year":"2020","journal-title":"J. Exp. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:13:24Z","timestamp":1757913204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925004345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":61,"alternative-id":["S1567576925004345"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114444","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: Multi-center, randomized, controlled trials","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114444"}}